People who maintain normal blood pressure, avoid diabetes and don't smoke between ages 48 and 68 experience nearly 13 additional years without dementia compared to those with all three risk factors, according to a major longitudinal study published this week in Neurology® Open Access.
The study, led by researchers at NYU Langone Health and drawing on nearly four decades of data from the Atherosclerosis Risk in Communities (ARIC) Study, analyzed 12,409 dementia-free participants with an average age of 56. Over 26 years of follow-up, 3,008 participants developed dementia, while 5,238 died without developing the condition.
Participants with zero vascular risk factors averaged 30 years without dementia onset, compared to just 17 years for those carrying all three risk factors.
The research documents significant demographic disparities in dementia-free lifespans. Women showed longer periods without dementia than men across all risk categories. Among participants with all three risk factors, women lived an average of 18.1 years without dementia, while men averaged 16.6 years.
The data also exposed a racial health gap. White participants with all three risk factors lived an average of 19.6 years without developing dementia, compared to 16 years for Black participants—a gap of 3.6 years, or 18 percent.
"Our findings argue that people need to actively avert these factors in midlife as a strategy for preserving brain health for more than a decade," said Josef Coresh, MD, PhD, founding director of NYU Langone's Optimal Aging Institute and senior investigator on the study. "These results suggest that vascular risk reduction may benefit all groups, but that certain populations, such as Black adults, may especially benefit from targeted prevention efforts."
With 42 percent of Americans at risk for developing dementia after age 55, the window for intervention is narrowing even as the population ages.
The three modifiable risk factors examined are well-established in cardiovascular epidemiology. Hypertension damages blood vessel endothelium and reduces cerebral blood flow. Diabetes accelerates neuroinflammation and amyloid accumulation. Smoking introduces oxidative stress and damages the blood-brain barrier.
The research documents correlation, not causation. The study measured these risk factors at a single point in time, capturing a snapshot rather than tracking changes over decades. Additionally, the ARIC cohort, though community-based, skews toward higher socioeconomic status and educational attainment compared to the general U.S. population, which may affect the generalizability of the findings.
The research team comprised epidemiologists from Johns Hopkins Bloomberg School of Public Health, the University of Minnesota, the University of Mississippi Medical Center, the National Institute of Neurological Disorders and Stroke, and NYU Langone. Their work was funded by National Institutes of Health grants.
For individuals, the data support intensified focus on vascular risk management in the critical 48-to-68 age window. For clinicians, the findings suggest hypertension, diabetes, and smoking status merit aggressive intervention during midlife screenings. For public health planners, the disparities flag where targeted prevention programs should concentrate resources.
The study does not address the intensity of intervention needed or distinguish between different levels of risk factor severity, which could refine intervention strategies.
As dementia prevalence climbs alongside population aging, prevention strategies become increasingly urgent. Translating these findings into equitable action—ensuring all populations receive the preventive care that generates these benefits—remains a priority.
